Literature DB >> 8215772

[Holter and sudden death: value in a case of arrhythmogenic right ventricular dysplasia].

P Aouate1, F Fontaliran, G Fontaine, R Frank, A Benassar, G Lascault, J Tonet, C Humbert, C Guérot.   

Abstract

The authors report the first case of arrhythmogenic right ventricular dysplasia presenting with a sudden death due to primary ventricular fibrillation (ventricular fibrillation not preceded by ventricular tachycardia) recorded by the Holter method. The patient was a 56 year old man whose only complaint was near syncopal case is the fact that it is the first documented case of ventricular fibrillation revealing arrhythmogenic right ventricular dysplasia, the diagnosis of which was made at autopsy. In addition, the Holter recording showed the factors which triggered the arrhythmia: the "trigger" of 4 monomorphic ventricular extrasystoles during the minute preceding the ventricular fibrillation; the arrhythmogenic substrate giving rise to late ventricular potentials and, finally, the analysis of the R-R intervals suggesting a role of the sympathetic and parasympathetic nervous systems. Holter recordings could help identify subjects at high risk of severe ventricular arrhythmias.

Entities:  

Mesh:

Year:  1993        PMID: 8215772

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  3 in total

Review 1.  The arrhythmogenic right ventricle. Dysplasia versus cardiomyopathy.

Authors:  G Fontaine; F Fontaliran; F R Andrade; E Velasquez; J Tonet; X Jouven; Y Fujioka; R Frank
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

2.  Selective right ventricular angiography in apparently idiopathic ventricular fibrillation.

Authors:  S Peters; J Tröster; C A Hartwig; G H Reil
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

Review 3.  Noninvasive risk stratification in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Pietro Turrini; Domenico Corrado; Cristina Basso; Andrea Nava; Gaetano Thiene
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.